Form 8-K - Current report:
SEC Accession No. 0001808805-22-000030
Filing Date
2022-03-31
Accepted
2022-03-31 16:05:06
Documents
14
Period of Report
2022-03-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K naut-20220330.htm   iXBRL 8-K 41948
2 EX-99.1 exhibit991-8k033122.htm EX-99.1 18180
  Complete submission text file 0001808805-22-000030.txt   237663

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT naut-20220330.xsd EX-101.SCH 2156
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT naut-20220330_def.xml EX-101.DEF 6754
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT naut-20220330_lab.xml EX-101.LAB 30049
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT naut-20220330_pre.xml EX-101.PRE 18455
8 EXTRACTED XBRL INSTANCE DOCUMENT naut-20220330_htm.xml XML 12406
Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Filer) CIK: 0001808805 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39434 | Film No.: 22792385
SIC: 3826 Laboratory Analytical Instruments